![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/53 | (2006.01) |
A61K 31/53 | (2013.01) | ||
A61P 1/16 | (2006.01) | ||
A61P 1/16 | (2018.01) | ||
A61P 3/06 | (2006.01) | ||
A61P 3/06 | (2018.01) | ||
A61P 43/00 | (2006.01) | ||
A61P 43/00 | (2018.01) |
(11) | Patento numeris | 3528817 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17804979.7 |
Europos patento paraiškos padavimo data | 2017-10-18 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-08-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-05-25 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2017/057203 |
Data | 2017-10-18 |
(87) | Numeris | WO 2018/075650 |
Data | 2018-04-26 |
(30) | Numeris | Data | Šalis |
201662409833 P | 2016-10-18 | US | |
201762516594 P | 2017-06-07 | US |
(72) |
TAUB, Rebecca , US
|
(73) |
Madrigal Pharmaceuticals, Inc. ,
200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania 19428,
US
|
(54) | METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST |
METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST |